Copart (CPRT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for December 5, 2025, at the Dallas, TX headquarters.
Proxy materials and annual report are available online for review and voting.
Shareholders are encouraged to vote electronically or request paper materials by November 25, 2025.
Voting matters and shareholder proposals
Election of twelve directors to serve until the 2026 annual meeting or until successors are qualified.
Advisory (non-binding) vote on executive compensation for the fiscal year ended July 31, 2025.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending July 31, 2026.
Board of directors and corporate governance
Twelve nominees listed for election to the board, including Willis J. Johnson, A. Jayson Adair, and others.
Board recommends voting FOR all director nominees and proposals.
Latest events from Copart
- Quarterly net income fell 9.5% as U.S. revenue declined and cash reserves surged.CPRT
Q2 20263 Mar 2026 - Expanding into wholesale and specialty auctions, supported by land assets and a global network.CPRT
Baird 2024 Global Consumer, Technology, & Services Conference1 Feb 2026 - Full-year revenue and net income rose over 9%, but Q4 margins and profit declined.CPRT
Q4 202422 Jan 2026 - Revenue up 12.4%, net income up 8.9%, and cash reserves hit $3.7B in Q1 FY2025.CPRT
Q1 202513 Jan 2026 - Revenue up 14%, net income up 19%, and cash reserves more than doubled.CPRT
Q2 20257 Jan 2026 - Record financial results, strong governance, and sustainability drive key 2025 proxy actions.CPRT
Proxy Filing1 Dec 2025 - Record results, strong governance, and key votes on directors, pay, and auditor at annual meeting.CPRT
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification up for vote at annual meeting.CPRT
Proxy Filing1 Dec 2025 - Net income up 11.5% to $404M, cash doubles, margins improve; DOJ probe and market risks persist.CPRT
Q1 202624 Nov 2025